616 related articles for article (PubMed ID: 27993856)
1. Real-Time Monitoring of
Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
[TBL] [Abstract][Full Text] [Related]
2. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
Ahmed MN; Porse A; Abdelsamad A; Sommer M; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Mulet X; Maciá MD; Mena A; Juan C; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2009 Apr; 53(4):1552-60. PubMed ID: 19188376
[TBL] [Abstract][Full Text] [Related]
4. nfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosa.
Monti MR; Morero NR; Miguel V; Argaraña CE
PLoS One; 2013; 8(6):e66236. PubMed ID: 23762483
[TBL] [Abstract][Full Text] [Related]
5. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.
Jeannot K; Elsen S; Köhler T; Attree I; van Delden C; Plésiat P
Antimicrob Agents Chemother; 2008 Jul; 52(7):2455-62. PubMed ID: 18474583
[TBL] [Abstract][Full Text] [Related]
6. Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators.
Morero NR; Monti MR; Argaraña CE
Antimicrob Agents Chemother; 2011 Aug; 55(8):3668-76. PubMed ID: 21646492
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.
Mulet X; Moyá B; Juan C; Macià MD; Pérez JL; Blázquez J; Oliver A
Antimicrob Agents Chemother; 2011 Oct; 55(10):4560-8. PubMed ID: 21807976
[TBL] [Abstract][Full Text] [Related]
8. EsrC, an envelope stress-regulated repressor of the mexCD-oprJ multidrug efflux operon in Pseudomonas aeruginosa.
Purssell A; Fruci M; Mikalauskas A; Gilmour C; Poole K
Environ Microbiol; 2015 Jan; 17(1):186-98. PubMed ID: 25143244
[TBL] [Abstract][Full Text] [Related]
9. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa.
Purssell A; Poole K
Microbiology (Reading); 2013 Oct; 159(Pt 10):2058-2073. PubMed ID: 23924707
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa.
Poole K; Gotoh N; Tsujimoto H; Zhao Q; Wada A; Yamasaki T; Neshat S; Yamagishi J; Li XZ; Nishino T
Mol Microbiol; 1996 Aug; 21(4):713-24. PubMed ID: 8878035
[TBL] [Abstract][Full Text] [Related]
12. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa.
Stickland HG; Davenport PW; Lilley KS; Griffin JL; Welch M
J Proteome Res; 2010 Jun; 9(6):2957-67. PubMed ID: 20373734
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.
Macià MD; Pérez JL; Molin S; Oliver A
Antimicrob Agents Chemother; 2011 Nov; 55(11):5230-7. PubMed ID: 21859941
[TBL] [Abstract][Full Text] [Related]
14. The effect of the sub-minimal inhibitory concentration and the concentrations within resistant mutation window of ciprofloxacin on MIC, swimming motility and biofilm formation of Pseudomonas aeruginosa.
Shi N; Gao Y; Yin D; Song Y; Kang J; Li X; Zhang Z; Feng X; Duan J
Microb Pathog; 2019 Dec; 137():103765. PubMed ID: 31586475
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a ciprofloxacin/amikacin combination against planktonic and biofilm cultures of susceptible and low-level resistant Pseudomonas aeruginosa.
Soares A; Alexandre K; Lamoureux F; Lemée L; Caron F; Pestel-Caron M; Etienne M
J Antimicrob Chemother; 2019 Nov; 74(11):3252-3259. PubMed ID: 31424553
[TBL] [Abstract][Full Text] [Related]
16. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump.
Morita Y; Komori Y; Mima T; Kuroda T; Mizushima T; Tsuchiya T
FEMS Microbiol Lett; 2001 Aug; 202(1):139-43. PubMed ID: 11506922
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes.
Peng J; Cao J; Ng FM; Hill J
J Proteomics; 2017 Jan; 152():75-87. PubMed ID: 27771372
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms decreasing in vitro susceptibility to the LpxC inhibitor CHIR-090 in the gram-negative pathogen Pseudomonas aeruginosa.
Caughlan RE; Jones AK; Delucia AM; Woods AL; Xie L; Ma B; Barnes SW; Walker JR; Sprague ER; Yang X; Dean CR
Antimicrob Agents Chemother; 2012 Jan; 56(1):17-27. PubMed ID: 22024823
[TBL] [Abstract][Full Text] [Related]
19. A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance.
Thai VC; Pham HV; Nguyen DNM; Lambert P; Nguyen TTH
Acta Microbiol Immunol Hung; 2017 Sep; 64(3):245-253. PubMed ID: 28560883
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
